Sertraline-Induced Galactorrhoea: A Case Report
Jihane Moussaoui, Mohammed Barrimi

TL;DR
This case report describes a patient who developed galactorrhoea while taking Sertraline, a type of antidepressant.
Contribution
The novelty lies in reporting galactorrhoea as a rare side effect of Sertraline, a selective serotonin reuptake inhibitor.
Findings
A patient developed galactorrhoea while on Sertraline treatment.
Sertraline-induced galactorrhoea is rare and not commonly reported in the literature.
The case highlights the need for awareness of this potential side effect in clinical practice.
Abstract
Patients taking various treatments frequently report galactorrhoea as a side effect. Psychotropic drugs, especially neuroleptics, are among the treatments most likely to cause this effect. Conventional tricyclic antidepressants rarely cause galactorrhea. The advent of new selective serotonin reuptake inhibitor (SSRI) antidepressants purported to reduce such side effects. We report the clinical case of a patient with galactorrhoea on Sertraline as well as our therapeutic approach in light of data from recent scientific literature.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBotulinum Toxin and Related Neurological Disorders · Cancer Treatment and Pharmacology · Pharmacological Effects and Toxicity Studies
